Cingulate Inc

/Cingulate Inc

IPO

Cingulate Inc

Biopharmaceutical

We are a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Symbol

CING

Price Range
$6.00 - $8.00

Final Shares
3,571,428

Anticipated Date
December 8, 2021

Underwriters
AEGIS CAPITAL CORP.

This offering is orderable

To view the prospectus for Cingulate Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange